Meenakshi Devidas

37.3k citations

311 papers · 12.6k indexed · 4 hit papers · h-index 59

Impact in

Hematology top 0.1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
Pediatrics, Perinatology and Child Health top 0.05%
- Childhood Cancer Survivors' Quality of Life

Papers in

Hematology 105
- Acute Myeloid Leukemia Research 61
- Chronic Myeloid Leukemia Treatments 42
Public Health, Environmental and Occupational Health 250
- Acute Lymphoblastic Leukemia research 241

Co-authors: Stephen P. Hunger William L. Carroll Naomi Winick Bruce M. Camitta Elizabeth A. Raetz Paul S. Gaynon Michael J. Borowitz Mignon L. Loh
Journals: Blood (104 papers)Journal of Clinical Oncology (66 papers)Pediatric Blood & Cancer (25 papers)Leukemia (17 papers)Cancer (10 papers)
Partner nations: United States Canada Switzerland

In The Last Decade

Meenakshi Devidas

299 papers receiving 12.3k citations

Hit Papers

align trajectories log scale

Effect of Postreinduction Therapy Consolidation With Blinatumomab vs Chemotherapy on Disease-Free Survival in Children, Adolescents, and Young Adults With First Relapse of B-Cell Acute Lymphoblastic Leukemia 2021 · 207 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2021 JAMA
2014 Leukemia
2012 Journal of Clinical Oncology
2008 Blood

Peers

Countries citing papers authored by Meenakshi Devidas

Since Specialization

Citations

This map shows the geographic impact of Meenakshi Devidas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meenakshi Devidas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meenakshi Devidas more than expected).

Fields of papers citing papers by Meenakshi Devidas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meenakshi Devidas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meenakshi Devidas. The network helps show where Meenakshi Devidas may publish in the future.

Co-authors

The 25 scholars most cited alongside Meenakshi Devidas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Meenakshi Devidas Line = papers co-authored together Meenakshi Devidas links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Comprehensive analysis of MYB/MYBL1-altered pediatric-type diffuse low-grade glioma UNC Libraries ·Paul Klimo, Nurjumiati Nurjumiati, Matthew D. Wood, Г.К. Кривоконева, Alan Davidson, Xiaoyu Li, Giles Robinson, Daniel C. Moreira, 江理加納, Jason Chiang, 黄显达, Ibrahim Qaddoumi, Thomas W. Bouldin, Meenakshi Devidas, Amar Gajjar, Ryuma Tanaka, Godwin Job	2024	1
2	Impact of the COVID‐19 pandemic on pediatric oncology providers globally: A mixed‐methods study Cancer ·V. F. Ostashko, Dylan E. Graetz, Asya Agulnik, J. M. Korinek, Yuvanesh Vedaraju, Mathia Kirstein, Meenakshi Devidas, Guillermo Chantada, Laila Hessissen, Rashmi Dalvi, Kathy Pritchard‐Jones, Carlos Rodríguez‐Galindo, Daniel C. Moreira	2022	19
3	A Phase 3 Randomized Trial of Inotuzumab Ozogamicin for Newly Diagnosed High-Risk B-ALL: Safety Phase Results from Children's Oncology Group Protocol AALL1732 Blood ·Jennifer L. McNeer, Maureen M. O’Brien, Susan R. Rheingold, Meenakshi Devidas, Zhiguo Chen, Deepa Bhojwani, Anurag K. Agrawal, Brent Wood, Eugene Suh, Sarah Alexander, Tamara P. Miller, Olga Militano, Elizabeth A. Raetz, Mignon L. Loh	2021	8
4	A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in Low Risk (LR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs): A Report from Children's Oncology Group Study AALL1331 Blood ·Patrick A. Brown, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Laura Hogan, Teena Bhatla, Michael J. Borowitz, Elizabeth A. Raetz, Lia Gore, James A. Whitlock, Stephen P. Hunger, Mignon L. Loh	2021	7
5	Outcomes in adolescent and young adult patients (16 to 30 years) compared to younger patients treated for high-risk B-lymphoblastic leukemia: report from Children’s Oncology Group Study AALL0232 Leukemia ·Michael J. Burke, Meenakshi Devidas, Zhiguo Chen, Wanda L. Salzer, Elizabeth A. Raetz, Karen R. Rabin, Nyla A. Heerema, Andrew J. Carroll, Julie M. Gastier‐Foster, Michael J. Borowitz, Brent L. Wood, Naomi Winick, William L. Carroll, Stephen P. Hunger, Mignon L. Loh, Eric Larsen	2021	12
6	Impact of Asparaginase Discontinuation on Outcome in Childhood Acute Lymphoblastic Leukemia: A Report From the Children’s Oncology Group Journal of Clinical Oncology ·Sumit Gupta, Cindy Wang, Elizabeth A. Raetz, Reuven J. Schore, Wanda L. Salzer, Eric Larsen, Kelly W. Maloney, Gonzalo García Camacho, William L. Carroll, Naomi Winick, Stephen P. Hunger, Mignon L. Loh, Meenakshi Devidas	2020	124
7	Excellent Outcomes with Reduced Frequency of Vincristine and Dexamethasone Pulses in Children with National Cancer Institute (NCI) Standard-Risk B Acute Lymphoblastic Leukemia (SR B-ALL): A Report from Children's Oncology Group (COG) Study AALL0932 Blood ·Anne Angiolillo, Reuven J. Schore, John A. Kairalla, Meenakshi Devidas, Karen R. Rabin, Patrick A. Zweidler‐McKay, Michael J. Borowitz, Brent L. Wood, Andrew J. Carroll, Nyla A. Heerema, Mary V. Relling, Jian-chao, Kelly W. Maloney, Cindy Wang, William L. Carroll, Naomi Winick, Elizabeth A. Raetz, Mignon L. Loh, Stephen P. Hunger	2019	4
8	A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk (HR/IR) First Relapse of B-Acute Lymphoblastic Leukemia (B-ALL) in Children and Adolescents/Young Adults (AYAs) Demonstrates Superior Efficacy and Tolerability of Blinatumomab: A Report from Children's Oncology Group Study AALL1331 Blood ·Patrick A. Brown, Lingyun Ji, Xinxin Xu, Meenakshi Devidas, Laura Hogan, Michael J. Borowitz, Elizabeth A. Raetz, Gerhard Zugmaier, Elad Sharon, Lia Gore, James A. Whitlock, Michael A. Pulsipher, Stephen P. Hunger, Mignon L. Loh	2019	51
9	Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL Blood ·Brent L. Wood, David Wu, Beryl Crossley, Yunfeng Dai, David Williamson, Charles Gawad, Michael J. Borowitz, Meenakshi Devidas, Kelly W. Maloney, Eric Larsen, Naomi Winick, Elizabeth A. Raetz, William L. Carroll, Stephen P. Hunger, Mignon L. Loh, Harlan Robins, Ilan Kirsch	2017	130
10	Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy Journal of Clinical Oncology ·Ajay Vora, Anita Andreano, Ching‐Hon Pui, Stephen P. Hunger, Martin Schrappe, Anja Moericke, Andrea Biondi, Gabriele Escherich, Lewis B. Silverman, Nicholas Goulden, Mervi Taskinen, Rob Pieters, Keizo Horibe, Meenakshi Devidas, Franco Locatelli, Maria Grazia Valsecchi	2016	75
11	Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232 Journal of Clinical Oncology ·Eric Larsen, Meenakshi Devidas, Si Chen, Wanda L. Salzer, Elizabeth A. Raetz, Mignon L. Loh, Leonard A. Mattano, Catherine Cole, زهرا آپند, Maryse Guinebretière, Jennifer Boss, Nyla A. Heerema, Christian M. Merz, Julie M. Gastier‐Foster, Michael J. Borowitz, Brent L. Wood, Cheryl L. Willman, Naomi Winick, Stephen P. Hunger, William L. Carroll	2016	231
12	Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children’s Oncology Group Randomized Trial Pediatric Oncology Group 9404 Journal of Clinical Oncology ·Barbara L. Asselin, Meenakshi Devidas, Lu Chen, Vivian I. Franco, Jeanette Pullen, Michael J. Borowitz, R. Hutchison, Yaddanapudi Ravindranath, Saro H. Armenian, Bruce M. Camitta, Steven E. Lipshultz	2015	145
13	Outstanding Outcome for Children with Standard Risk-Low (SR-Low) Acute Lymphoblastic Leukemia (ALL) and No Benefit to Intensified Peg-Asparaginase (PEG-ASNase) Therapy: Results of Children’s Oncology Group (COG) Study AALL0331 Blood ·Leonard A. Mattano, Meenakshi Devidas, Alison M. Friedmann, Elizabeth A. Raetz, Mignon L. Loh, Patrick J. Buckley, Michael J. Borowitz, Andrew J. Carroll, Julie M. Gastier‐Foster, Nyla A. Heerema, Nina S. Kadan‐Lottick, Yousif Matloub, David T. Marshall, Linda C. Stork, Brent L. Wood, Naomi Winick, Stephen P. Hunger, William L. Carroll, Kelly W. Maloney	2014	13
14	Genome-wide study of methotrexate clearance replicates SLCO1B1 Blood ·Laura B. Ramsey, John C. Panetta, Colton Smith, Wenjian Yang, Yiping Fan, Naomi Winick, Paul L. Martin, Cheng Cheng, Meenakshi Devidas, Ching‐Hon Pui, William E. Evans, Stephen P. Hunger, Mignon L. Loh, Mary V. Relling	2012	157
15	Postrelapse survival in childhood acute lymphoblastic leukemia is independent of initial treatment intensity: a report from the Children's Oncology Group Blood ·David R. Freyer, Meenakshi Devidas, Mei La, William L. Carroll, Paul S. Gaynon, Stephen P. Hunger, Nita L. Seibel	2010	58
16	Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia Blood ·Richard C. Harvey, Charles G. Mullighan, I‐Ming Chen, Walker Wharton, Fady M. Mikhail, Andrew J. Carroll, Huining Kang, Wei Liu, Kevin K. Dobbin, Malcolm A. Smith, William L. Carroll, Meenakshi Devidas, W. Paul Bowman, Bruce M. Camitta, Gregory H. Reaman, Stephen P. Hunger, James R. Downing, Cheryl L. Willman	2010	395
17	Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study Journal of Clinical Oncology ·Linda Granowetter, Richard B. Womer, Meenakshi Devidas, Mark Krailo, Chenguang Wang, Mark L. Bernstein, Neyssa Marina, Patrick J. Leavey, Mark C. Gebhardt, John H. Healey, Robert C. Shamberger, Allen M. Goorin, James S. Miser, James S. Meyer, Carola A.S. Arndt, Scott L. Sailer, Karen J. Marcus, Elizabeth J. Perlman, Paul S. Dickman, Holcombe E. Grier	2009	235
18	Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study Journal of Clinical Oncology ·Kirk R. Schultz, W. Paul Bowman, Alexander Aledo, William B. Slayton, Harland N. Sather, Meenakshi Devidas, Chenguang Wang, Stella M. Davies, Paul S. Gaynon, Michael E. Trigg, Robert Rutledge, Laura Burden, Liu Changla, Andrew J. Carroll, Nyla A. Heerema, Naomi Winick, Michael J. Borowitz, Stephen P. Hunger, William L. Carroll, Bruce M. Camitta	2009	436
19	Prospective Analysis of TEL Gene Rearrangements in Childhood Acute Lymphoblastic Leukemia: A Children's Oncology Group Study Journal of Clinical Oncology ·Jeffrey E. Rubnitz, David Wichlan, Meenakshi Devidas, Jonathan J. Shuster, Stephen B. Linda, Joanne Kurtzberg, Beverly Bell, Stephen P. Hunger, Allen R. Chauvenet, Ching‐Hon Pui, Bruce M. Camitta, Jeanette Pullen	2008	53
20	Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201 Blood ·Allen R. Chauvenet, Paul L. Martin, Meenakshi Devidas, Stephen B. Linda, Beverly Bell, Joanne Kurtzberg, Jeanette Pullen, Mark J. Pettenati, Andrew J. Carroll, Jonathan J. Shuster, Bruce M. Camitta	2007	40

About Meenakshi Devidas

Meenakshi Devidas is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health, Genetics and Speech and Hearing, having authored 311 papers that have together received 12.6k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (241 papers), Childhood Cancer Survivors' Quality of Life (150 papers), Acute Myeloid Leukemia Research (61 papers), Chronic Myeloid Leukemia Treatments (42 papers), Lymphoma Diagnosis and Treatment (32 papers), Chronic Lymphocytic Leukemia Research (28 papers), Neuroblastoma Research and Treatments (20 papers) and Adolescent and Pediatric Healthcare (17 papers). The work is most often cited by research in Hematology (4.5k citations), Pediatrics, Perinatology and Child Health (5.5k citations), Public Health, Environmental and Occupational Health (8.0k citations), Speech and Hearing (719 citations) and Oncology (2.8k citations). Meenakshi Devidas has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include Stephen P. Hunger, William L. Carroll, Naomi Winick, Bruce M. Camitta, Elizabeth A. Raetz, Paul S. Gaynon, Michael J. Borowitz, Mignon L. Loh, Andrew J. Carroll and Xiaomin Lu. Their work appears in journals such as Blood, Journal of Clinical Oncology, Pediatric Blood & Cancer, Leukemia and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact